首页> 外文OA文献 >Recent Advances in Immunopathophysiology of Interleukin-6: An Innovative Therapeutic Drug, Tocilizumab (Recombinant Humanized Anti-human Interleukin-6 Receptor Antibody), Unveils The Mysterious Etiology of Immune-Mediated Inflammatory Diseases

【2h】

Recent Advances in Immunopathophysiology of Interleukin-6: An Innovative Therapeutic Drug, Tocilizumab (Recombinant Humanized Anti-human Interleukin-6 Receptor Antibody), Unveils The Mysterious Etiology of Immune-Mediated Inflammatory Diseases

机译：白细胞介素-6免疫病理学的最新进展：一种创新的治疗药物，对普查珠三粒草（重组人源化抗人白细胞介素-6受体抗体），推出了免疫介导的炎症疾病的神秘病因

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Yoshiyuki Ohsugi;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Recent Advances in Immunopathophysiology of Interleukin-6:An Innovative Therapeutic Drug,Tocilizumab(Recombinant Humanized Anti-human Interleukin-6 Receptor Antibody),Unveils The Mysterious Etiology of Immune-Mediated Inflammatory Diseases [J] . Yoshiyuki OHSUGI Biological & pharmaceutical bulletin . 2007,第11期

机译：白细胞介素-6的免疫病理生理学的最新进展：一种创新的治疗药物Tocilizumab（重组人源化抗人白细胞介素6受体抗体），揭示了免疫介导的炎性疾病的神秘病因
2. Therapeutic Implications of Tocilizumab, A Humanized Anti-Interleukin-6 Receptor Antibody, for Various Immune-Mediated Diseases: An Update Review [J] . Toshio Tanaka Atsushi Ogata Yoshihito Shima Masashi Narazaki Atsushi Kumanogoh Tadamitsu Kishimoto Current Rheumatology Reviews . 2012,第3期

机译：人源化抗白介素6受体抗体Tocilizumab对多种免疫介导疾病的治疗意义：最新进展
3. Efficacy of tocilizumab, a humanized neutralizing antibody against interleukin-6 receptor, in progressive renal injury associated with Castleman's disease [J] . Akito Maeshima, Masao Nakasatomi, Daizo Henmi, CEN Case Reports . 2012,第1期

机译：抗人白介素6受体的人源化中和抗体tocilizumab在与Castleman病相关的进行性肾损伤中的功效
4. Efficacy of tocilizumab a humanized neutralizing antibody against interleukin-6 receptor in progressive renal injury associated with Castlemans disease [O] . Akito Maeshima, Masao Nakasatomi, Daizo Henmi, 2012

机译：抗人白介素6受体的人源化中和抗体tocilizumab在与Castleman病相关的进行性肾损伤中的功效
5. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study [O] . Mark C. Genovese, James D. McKay, Evgeny L. Nasonov, 2008

机译：白细胞介素-6受体抑制与巯基霉素可减少类风湿性关节炎的疾病活性，对疾病改性的抗胃部药物的反应不足：与传统疾病修饰的抗胃部药物治疗研究组合的Tocolizumab

Recent Advances in Immunopathophysiology of Interleukin-6: An Innovative Therapeutic Drug, Tocilizumab (Recombinant Humanized Anti-human Interleukin-6 Receptor Antibody), Unveils The Mysterious Etiology of Immune-Mediated Inflammatory Diseases

著录项

引文网络

相似文献

相关主题

期刊订阅